Vulnerabilities related to the pandemic are amplifying the threat of cyberattacks on health networks. Understanding key IoMT-associated risks can help mitigate risk and minimize the potential scope of damage.
The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.
ISMP says common medication mishaps can be prevented with proper attention and prioritization that results in system and practice changes.
Guidance published by Oregon Health & Science University scientists outlines a preoperative protocol for surgical care teams to evaluate the readiness of previously COVID-positive patients for elective procedures.